FDAnews
www.fdanews.com/articles/156440-scotus-8220-pay-for-delay-8221-decision-provides-roadmap-for-case-by-case-crackdown

SCOTUS “Pay-for-Delay” Decision Provides Roadmap for Case-by-Case Crackdown

June 18, 2013
“Pay-for-delay” deals between brand drugmakers and their generic competitors can sometimes violate antitrust law, the Supreme Court ruled Monday, issuing a tempered decision that will make it easier for legal challenges to be brought by critics of the practice.
Drug Industry Daily